SCHEMBL9890190

SCHEMBL9890190

c1ccc2c(c1)c1ncccc1n2-c1ccc2oc3c(ccc4c5cc(-n6c7ccccc7c7ncccc76)ccc5oc43)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.37
MAPT P10636 5/20 0.36
TSHR P16473 4/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 4/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
RAB9A P51151 3/20 0.35
HTT P42858 2/20 0.35
USP2 O75604 1/20 0.35
LIMK1 P53667 1/20 0.35
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HSD17B10 Q99714 2/20 0.34
PDE4D Q08499 2/20 0.34
HCRTR1 O43613 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4570442 0.93 MAPT (0.40) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL9890446 0.93 MAPT (0.35) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL9890201 0.92 NCOA1 (0.34) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL16625755 0.91 MAPT (0.39) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL9890117 0.91 MAPT (0.39) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL5028376 0.90 TSHR (0.33) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL9890376 0.90 MAPT (0.38) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL21610892 0.89 TSHR (0.33) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL16625763 0.88 MAPT (0.43) NCOA1MAPTTSHRLMNASMN1; SMN2
SCHEMBL17264907 0.88 MAPT (0.43) NCOA1MAPTTSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 NCOA1 1720/4885MAPT 1303/4885TSHR 4767/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 NCOA1 1720/4885MAPT 1303/4885TSHR 4767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.